Live from the NIH registry
Studies recruiting near Gainesville right now
Top 25 of 146 recruiting studies, sorted by proximity — each links to its official registry page
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Northeast Georgia Medical Center-Gainesville — Gainesville, Georgia (0.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Duluth, GA Investigative Site 10083 — Duluth, Georgia (26.8 mi)
· Sponsor: Colorado Prevention Center
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50566 — Gainesville, Georgia (0.6 mi)
· Sponsor: UCB Biopharma SRL
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 144 participants sought
Cleaver Medical Group Dermatology- Site Number : 8400008 — Cumming, Georgia (18.7 mi)
· Sponsor: Sanofi
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Gainesville, Georgia (0.6 mi)
· Sponsor: Akero Therapeutics, Inc
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
Coronary Artery Disease, High Risk Percutaneous Coronary Intervention
N/A
Interventional 358 participants sought
Northside Hospital — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Supira Medical
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
ProCare Prosthetics x Ottobock.care — Buford, Georgia (15.4 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 2
Interventional 60 participants sought
Investigator Site # 1 — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Akebia Therapeutics
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Obesity, Overweight
Phase 3
Interventional 3,600 participants sought
ACCOMPLISH-1 Research Site — Buford, Georgia (15.4 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis
Phase 3
Interventional 225 participants sought
Georgia Nephrology Research Inst — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
NSC Research Inc — Johns Creek, Georgia (27.8 mi)
· Sponsor: Boehringer Ingelheim
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Ovarian Cancer
Phase 2
Interventional 160 participants sought
Northeast Georgia Medical Center Gainesville — Gainesville, Georgia (0.6 mi)
· Sponsor: Incyte Corporation
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
Iron Deficiency Anemia
Phase 3
Interventional 75 participants sought
Gwinnett Research Institute — Buford, Georgia (15.4 mi)
· Sponsor: AMAG Pharmaceuticals, Inc.
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Suwanee, Georgia (21.5 mi)
· Sponsor: AstraZeneca
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Alzheimers Disease
Phase 3
Interventional 800 participants sought
Center for Advanced Research & Education — Gainesville, Georgia (0.6 mi)
· Sponsor: Hoffmann-La Roche
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Sleep Apnea, Obstructive, Obesity
Phase 3
Interventional 800 participants sought
Teak Research Consults — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 1,500 participants sought
Cleaver Medical Group Dermatology /ID# 259801 — Dawsonville, Georgia (18.8 mi)
· Sponsor: AbbVie
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Northeast Georgia Medical Ctr — Gainesville, Georgia (0.6 mi)
· Sponsor: Novo Nordisk A/S
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
One Health Research Clinic Inc. — Johns Creek, Georgia (27.8 mi)
· Sponsor: pH-D Feminine Health LLC
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Teak Research Consults — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Eli Lilly and Company
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF)
Phase 2
Interventional 1,200 participants sought
NSC Research, Inc — Johns Creek, Georgia (27.8 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Gainesville, Georgia (0.6 mi)
· Sponsor: Akero Therapeutics, Inc
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Liver Neoplasms, Primary Liver Cancer
N/A
Observational 5,000 participants sought
Northeast Georgia Medical Center — Gainesville, Georgia (0.6 mi)
· Sponsor: HistoSonics, Inc.
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Northeast Georgia Medical Center-Gainesville — Gainesville, Georgia (0.6 mi)
· Sponsor: SWOG Cancer Research Network